Your session is about to expire
← Back to Search
EEG for Prediction Error in Anorexia
N/A
Waitlist Available
Led By Guido Frank, MD
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Healthy body weight between 90 and 110 % average body weight.
Healthy body weight between 90 and 110 % average body weight
Must not have
Current Medications other than BCP or IUD
chronic obstructive pulmonary disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediate during brain scanning
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing the feasibility of using electroencephalography (EEG) to study adolescent anorexia nervosa (AN), with the goal of eventually replacing more costly and difficult-to-access fMRI.
Who is the study for?
This trial is for girls aged 11-17 with Anorexia Nervosa (AN), specifically the restricting type, and healthy controls within a similar age range. Participants must have a body weight below 17.5 BMI if diagnosed with AN or between 90-110% of average body weight if they are healthy controls. All participants should be right-handed as per the Edinburgh Handedness Inventory, speak English primarily, and for those with AN, be in their first weeks of treatment at specified centers.
What is being tested?
The study aims to develop an EEG-based method to investigate prediction error responses in adolescents with AN compared to healthy controls. It will adapt existing fMRI protocols for EEG use and test whether these can reliably measure brain responses related to reward processing errors across different stimuli like taste and money.
What are the potential side effects?
Since this trial involves non-invasive EEG testing rather than medication or invasive procedures, there are minimal expected side effects. The main concerns may include discomfort from wearing the EEG cap or stress from participating in the tasks required by the study.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My weight is within the normal range for my height.
Select...
My weight is within the normal range for my height.
Select...
I am diagnosed with anorexia, have a BMI under 17.5, fear gaining weight, see my body differently, and if applicable, haven't had a menstrual cycle for over three months.
Select...
I am in my first 1-2 weeks of treatment at UC San Diego or Rady Children's Hospital.
Select...
I am in my first 1-2 weeks of treatment at UC San Diego or Rady Children's Hospital.
Select...
I am diagnosed with anorexia, have a BMI under 17.5, fear gaining weight, see my body differently, and if applicable, haven't had a menstrual cycle for over three months.
Select...
I am a female between 11 and 17 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am taking medications other than birth control pills or IUDs.
Select...
I have chronic obstructive pulmonary disease.
Select...
I am on medication to prevent blood clots.
Select...
I have heart disease.
Select...
I do not have any life-threatening conditions.
Select...
I am paralyzed in my legs or in all four limbs.
Select...
I am living with HIV/AIDS.
Select...
I have a seizure disorder.
Select...
I have sickle cell disease.
Select...
I have severe asthma.
Select...
I am legally blind.
Select...
I have been diagnosed with schizophrenia or a similar psychotic disorder.
Select...
I have been diagnosed with Alzheimer's disease or another form of dementia.
Select...
A close family member has or had an eating disorder.
Select...
I have never been diagnosed with bipolar disorder or psychosis.
Select...
I am experiencing depression with thoughts of suicide.
Select...
I have been diagnosed with Anorexia Nervosa.
Select...
I have diabetes with complications like blindness or kidney failure.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediate during brain scanning
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediate during brain scanning
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Electroencephalography
Monetary Reward Prediction Error Brain Response using EEG will show similar regional brain response compared to taste prediction error response.
Reward Prediction Error Brain Response using Electroencephalography (EEG) to separate healthy controls from individuals with anorexia nervosa.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Healthy Control GroupExperimental Treatment1 Intervention
Participants who are considered to be healthy controls
Group II: Anorexia Nervosa GroupExperimental Treatment1 Intervention
Participants with anorexia nervosa
Find a Location
Who is running the clinical trial?
University of California, San DiegoLead Sponsor
1,187 Previous Clinical Trials
1,576,800 Total Patients Enrolled
18 Trials studying Anorexia Nervosa
1,858 Patients Enrolled for Anorexia Nervosa
Guido Frank, MDPrincipal Investigator - University of California, San Diego
University of California, San Diego
5 Previous Clinical Trials
431 Total Patients Enrolled
5 Trials studying Anorexia Nervosa
431 Patients Enrolled for Anorexia Nervosa
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am taking medications other than birth control pills or IUDs.I have been diagnosed with depression.My weight is within the normal range for my height.I have chronic obstructive pulmonary disease.I am on medication to prevent blood clots.Participants must not have a type of eating disorder that involves binge eating and purging behaviors.I have heart disease.I do not have any life-threatening conditions.I am paralyzed in my legs or in all four limbs.I am living with HIV/AIDS.I have a seizure disorder.I have had a stroke.I have sickle cell disease.I have a condition that affects my ability to move.I have severe asthma.I am legally blind.My weight is within the normal range for my height.I have diabetes.I have a condition that causes me significant pain or discomfort.I suffer from migraines.I am diagnosed with anorexia, have a BMI under 17.5, fear gaining weight, see my body differently, and if applicable, haven't had a menstrual cycle for over three months.I have cancer.I have been diagnosed with schizophrenia or a similar psychotic disorder.I have high blood pressure related to heart disease.I have been diagnosed with Alzheimer's disease or another form of dementia.I have arthritis.I am in my first 1-2 weeks of treatment at UC San Diego or Rady Children's Hospital.I am in my first 1-2 weeks of treatment at UC San Diego or Rady Children's Hospital.I haven't taken any anti-psychotic or stimulant medications in the last week.You are strongly left-handed, with a score of more than +200 on the Edinburgh Handedness Inventory Revised (EHI-R) LQ test.You can speak and understand English fluently.A close family member has or had an eating disorder.I have never been diagnosed with bipolar disorder or psychosis.I am diagnosed with anorexia, have a BMI under 17.5, fear gaining weight, see my body differently, and if applicable, haven't had a menstrual cycle for over three months.I am experiencing depression with thoughts of suicide.I have been diagnosed with Anorexia Nervosa.I have diabetes with complications like blindness or kidney failure.Healthy individuals without any medical conditions.I am a female between 11 and 17 years old.You have the restricting type of anorexia nervosa.
Research Study Groups:
This trial has the following groups:- Group 1: Anorexia Nervosa Group
- Group 2: Healthy Control Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.